Joseph LoTurco

Prof. Joseph LoTurco


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ATAarti Tarkar
Aarti Tarkar
NLNiki T Loges
Niki T Loges
CSChristopher E Slagle
Christopher E Slagle
RFRichard John Bruce Francis
Richard John Bruce Francis
GDGerard W Dougherty
Gerard W Dougherty
HOHeymut Omran
Heymut Omran

1 June 2012 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
FCFuyi Chen
Fuyi Chen
JLJoseph LoTurco
Joseph LoTurco

21 December 2008 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JMJean-Bernard Manent
Jean-Bernard Manent
YWYu Wang
Yu Wang
YCYoonJeung Chang
YoonJeung Chang
MPMurugan Paramasivam
Murugan Paramasivam
JLJoseph LoTurco
Joseph LoTurco

24 April 2009 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
JLJoseph LoTurco
Joseph LoTurco
JMJean-Bernard Manent
Jean-Bernard Manent
FSFaez Sidiqi
Faez Sidiqi
In utero electroporation (IUE) has become a method of choice for rapid gain and loss of function studies in embryonic cerebral cortex. In this review we highlight some of the proven and recent advances in IUE technology that make it applicable to an increasingly wide array of experiments requiring spatial and temporal control of gene expression. Recently, cell-type–specific promoters and tamoxifen-gated cre-recombinase have been shown to work effectively with IUE. Experiments can now be designed and carried out to test whether and which cell-type–specific mechanisms operate within defined periods of neuronal migration and maturation. We have recently adapted this conditional expression approach to implement conditional rescue experiments. In conditional rescue, expression of an RNA interference (RNAi) target is restored by tamoxifen-induced cre-mediated recombination. An initial disruption in migration, and resultant malformation, caused by DCX RNAi was reversed by delayed re-expression of Dcx. In the future, combinations of spatially directed, cell-type–specific, and tamoxifen-gated transgene expression can be used to address the complex mechanisms likely to operate during development of cerebral cortex.

1 January 2015 in Development
Verified
Journal Article
Closed access
PDF file
FCFuyi Chen
Fuyi Chen
JRJoel Rosiene
Joel Rosiene
ACAlicia Che
Alicia Che
ABAlbert Becker
Albert Becker
JLJoseph LoTurco
Joseph LoTurco
The ability to induce targeted mutations in somatic cells in developing organisms and then track the fates of those cells is a powerful approach both for studying neural development and for modeling human disease. The CRISPR/Cas9 system allows for such targeted mutagenesis, and we therefore tested it in combination with a piggyBac transposase lineage labeling system to track the development of neocortical neural progenitors with targeted mutations in genes linked to neurodevelopmental disruptions and tumor formation. We show that sgRNAs designed to target PTEN successfully decreased PTEN expression, and led to neuronal hypertrophy and altered neuronal excitability. Targeting NF1, by contrast, caused increased astrocytogenesis at the expense of neurogenesis, and combined targeting of three tumor suppressors (PTEN, NF1 and P53) resulted in formation of glioblastoma tumors. Our results demonstrate that CRISPR/Cas9 combined with piggyBac transposase lineage labeling can produce unique models of neurodevelopmental disruption and tumors caused by somatic mutation in neural progenitors.

1 September 2011 in Neuroscience
Verified
Journal Article
Closed access
YWY. Wang
Y. Wang
XYX. Yin
X. Yin
GRG. Rosen
G. Rosen
LGL. Gabel
L. Gabel
SGS.M. Guadiana
S.M. Guadiana
JLJoseph LoTurco
Joseph LoTurco